166 related articles for article (PubMed ID: 31664161)
1. Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region.
Anyona SB; Hengartner NW; Raballah E; Ong'echa JM; Lauve N; Cheng Q; Fenimore PW; Ouma C; Lambert CG; McMahon BH; Perkins DJ
J Hum Genet; 2020 Jan; 65(2):99-113. PubMed ID: 31664161
[TBL] [Abstract][Full Text] [Related]
2. Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children.
Ouma C; Davenport GC; Garcia S; Kempaiah P; Chaudhary A; Were T; Anyona SB; Raballah E; Konah SN; Hittner JB; Vulule JM; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Feb; 131(2):289-99. PubMed ID: 21818580
[TBL] [Abstract][Full Text] [Related]
3. Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production.
Ouma C; Davenport GC; Were T; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
Hum Genet; 2008 Dec; 124(5):515-24. PubMed ID: 18972133
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria.
Ong'echa JM; Raballah EO; Kempaiah PM; Anyona SB; Were T; Davenport GC; Konah S; Vulule JM; Ouma C; Hittner JB; Perkins DJ
BMC Genet; 2011 Aug; 12():69. PubMed ID: 21819616
[TBL] [Abstract][Full Text] [Related]
5. Human NCR3 gene variants rs2736191 and rs11575837 alter longitudinal risk for development of pediatric malaria episodes and severe malarial anemia.
Onyango CO; Cheng Q; Munde EO; Raballah E; Anyona SB; McMahon BH; Lambert CG; Onyango PO; Schneider KA; Perkins DJ; Ouma C
BMC Genomics; 2023 Sep; 24(1):542. PubMed ID: 37704951
[TBL] [Abstract][Full Text] [Related]
6. Haplotype of non-synonymous mutations within IL-23R is associated with susceptibility to severe malaria anemia in a P. falciparum holoendemic transmission area of Kenya.
Munde EO; Raballah E; Okeyo WA; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):291. PubMed ID: 28427357
[TBL] [Abstract][Full Text] [Related]
7. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya.
Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C
BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365
[TBL] [Abstract][Full Text] [Related]
8. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality.
Anyona SB; Kempaiah P; Raballah E; Ouma C; Were T; Davenport GC; Konah SN; Vulule JM; Hittner JB; Gichuki CW; Ong'echa JM; Perkins DJ
Infect Immun; 2011 Dec; 79(12):4923-32. PubMed ID: 21969001
[TBL] [Abstract][Full Text] [Related]
9. Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels.
Okeyo WA; Munde EO; Okumu W; Raballah E; Anyona SB; Vulule JM; Ong'echa JM; Perkins DJ; Ouma C
BMC Immunol; 2013 Mar; 14():15. PubMed ID: 23521898
[TBL] [Abstract][Full Text] [Related]
10. Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in Kenyan children.
Achieng AO; Hengartner NW; Raballah E; Cheng Q; Anyona SB; Lauve N; Guyah B; Foo-Hurwitz I; Ong'echa JM; McMahon BH; Ouma C; Lambert CG; Perkins DJ
EBioMedicine; 2019 Jul; 45():290-302. PubMed ID: 31278068
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum.
Kisia LE; Kempaiah P; Anyona SB; Munde EO; Achieng AO; Ong'echa JM; Lambert CG; Chelimo K; Ouma C; Perkins DJ; Raballah E
BMC Med Genet; 2019 Aug; 20(1):140. PubMed ID: 31420016
[TBL] [Abstract][Full Text] [Related]
12. Reduced interferon (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality.
Kempaiah P; Anyona SB; Raballah E; Davenport GC; Were T; Hittner JB; Ong'echa JM; Perkins DJ
Hum Genet; 2012 Aug; 131(8):1375-91. PubMed ID: 22570109
[TBL] [Abstract][Full Text] [Related]
13. Complement component 3 mutations alter the longitudinal risk of pediatric malaria and severe malarial anemia.
Raballah E; Anyona SB; Cheng Q; Munde EO; Hurwitz IF; Onyango C; Ndege C; Hengartner NW; Pacheco MA; Escalante AA; Lambert CG; Ouma C; Obama HCJT; Schneider KA; Seidenberg PD; McMahon BH; Perkins DJ
Exp Biol Med (Maywood); 2022 Apr; 247(8):672-682. PubMed ID: 34842470
[TBL] [Abstract][Full Text] [Related]
14. A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.
Ouma C; Keller CC; Davenport GC; Were T; Konah S; Otieno MF; Hittner JB; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
Infect Immun; 2010 Jan; 78(1):453-60. PubMed ID: 19884328
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in CSF2 (5q31.1) is associated with longitudinal susceptibility to pediatric malaria, severe malarial anemia, and all-cause mortality in a high-burden malaria and HIV region of Kenya.
Kisia LE; Cheng Q; Raballah E; Munde EO; McMahon BH; Hengartner NW; Ong'echa JM; Chelimo K; Lambert CG; Ouma C; Kempaiah P; Perkins DJ; Schneider KA; Anyona SB
Trop Med Health; 2022 Jun; 50(1):41. PubMed ID: 35752805
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.
Ouma C; Davenport GC; Awandare GA; Keller CC; Were T; Otieno MF; Vulule JM; Martinson J; Ong'echa JM; Ferrell RE; Perkins DJ
J Infect Dis; 2008 Oct; 198(8):1219-26. PubMed ID: 18781863
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya.
Zhang L; Prather D; Vanden Eng J; Crawford S; Kariuki S; ter Kuile F; Terlouw D; Nahlen B; Lal AA; Slutsker L; Udhayakumar V; Shi YP
Malar J; 2010 Mar; 9():87. PubMed ID: 20350312
[TBL] [Abstract][Full Text] [Related]
18. Nonsynonymous amino acid changes in the α-chain of complement component 5 influence longitudinal susceptibility to
Raballah E; Wilding K; Anyona SB; Munde EO; Hurwitz I; Onyango CO; Ayieko C; Lambert CG; Schneider KA; Seidenberg PD; Ouma C; McMahon BH; Cheng Q; Perkins DJ
Front Genet; 2022; 13():977810. PubMed ID: 36186473
[No Abstract] [Full Text] [Related]
19. A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria.
Awandare GA; Ouma C; Keller CC; Were T; Otieno R; Ouma Y; Davenport GC; Hittner JB; Ong'echa JM; Ferrell R; Perkins DJ
Genes Immun; 2006 Oct; 7(7):568-75. PubMed ID: 16929348
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.
Munde EO; Okeyo WA; Anyona SB; Raballah E; Konah S; Okumu W; Ogonda L; Vulule J; Ouma C
Infect Immun; 2012 Dec; 80(12):4435-43. PubMed ID: 23045477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]